Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolution of dynamics of physico-chemical and mechanical properties of hydroxyapatite with fluorine addition and degradation stability of new matrices. | J Mech Behav Biomed Mater | 2022 | 36115175 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma. | J Gastrointest Oncol | 2022 | 36092347 | PubTator, text mining | PubMed |
| IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses. | Nat Commun | 2022 | 36075894 | PubTator, text mining | PubMed |
| Editorial: Rational design and preparation of nanostructured biomaterials. | Front Chem | 2022 | 36046727 | PubTator, text mining | PubMed |
| TBK1 and GABARAP family members suppress Coxsackievirus B infection by limiting viral production and promoting autophagic degradation of viral extracellular vesicles. | PLoS Pathog | 2022 | 36044516 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants. | PLoS One | 2022 | 36037157 | PubTator, text mining | PubMed |
| Rapid proliferation of anaerobic ammonium oxidizing bacteria using anammox-hydroxyapatite technology in a pilot-scale expanded granular sludge bed reactor. | Bioresour Technol | 2022 | 36031118 | PubTator, text mining | PubMed |
| Self-fluorescence property of octa-arginine functionalized hydroxyapatite nanoparticles aids in studying their intracellular fate in R1 ESCs. | Biochem Biophys Res Commun | 2022 | 36029534 | PubTator, text mining | PubMed |
| Properties of New Composite Materials Based on Hydroxyapatite Ceramic and Cross-Linked Gelatin for Biomedical Applications. | Int J Mol Sci | 2022 | 36012345 | PubTator, text mining | PubMed |
| Biomimetic Mineralization of Tooth Enamel Using Nanocrystalline Hydroxyapatite under Various Dental Surface Pretreatment Conditions. | Biomimetics (Basel) | 2022 | 35997431 | PubTator, text mining | PubMed |
| Metabolic adaption of cancer cells toward autophagy: Is there a role for ER-phagy? | Front Mol Biosci | 2022 | 35992272 | PubTator, text mining | PubMed |
| Reticulons 3 and 6 interact with viral movement proteins. | Mol Plant Pathol | 2022 | 35987858 | PubTator, text mining | PubMed |
| The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. | Front Immunol | 2022 | 35967413 | PubTator, text mining | PubMed |
| In Situ Formation of Copper Phosphate on Hydroxyapatite for Wastewater Treatment. | Nanomaterials (Basel) | 2022 | 35957081 | PubTator, text mining | PubMed |
| Bioactive Interpenetrating Hydrogel Networks Based on 2-Hydroxyethyl Methacrylate and Gelatin Intertwined with Alginate and Dopped with Apatite as Scaffolding Biomaterials. | Polymers (Basel) | 2022 | 35956626 | PubTator, text mining | PubMed |
| Effectiveness of China's Protected Areas in Mitigating Human Activity Pressure. | Int J Environ Res Public Health | 2022 | 35954691 | PubTator, text mining | PubMed |
| Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy. | Cells | 2022 | 35954167 | PubTator, text mining | PubMed |
| Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease. | Chin Med J (Engl) | 2022 | 35950774 | PubTator, text mining | PubMed |
| Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection. | Front Cell Infect Microbiol | 2022 | 35937687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=20